• The MDinteractive deadline for 2020 MIPS reporting is
    Monday, March 1, 2021.

  • MDinteractive is an approved CMS Qualified Registry for
    2020 and 2021.

  • CMS Publishes 2021 Final Rule. What will it mean for your practice?
    Check out our highlights blog here.

2021 MIPS Quality Benchmarks

What Are Quality Measure Benchmarks?

When a clinician or group submits measures for the Merit-based Incentive Payment System (MIPS) quality performance category, each measure is assessed against its benchmark to determine how many points the measure earns. In program year 2020, a clinician or group can receive anywhere from 3 to 10 points* for each MIPS measure (not including any bonus points) that meets the data completeness standards and case minimum requirements through Benchmarks. Benchmarks are specific to the collection type: Qualified Clinical Data Registry (QCDR) measures, MIPS Clinical Quality Measures (MIPS CQMs)*, eCQMs, CMS Web Interface measures, the Consumer Assessment of Healthcare Providers and Systems (CAHPS) for MIPS survey, and Part B Claims measures. In order to measure performance that is comparable across the spectrum of performance, benchmarks are established using historical data. Historical benchmarks are based on actual performance data from 2018 that was submitted to the Quality Payment Program (QPP) in 2018.  *MIPS CQMs are measures submitted using registry rules.

How Are Benchmarks Displayed?

Each benchmark is presented in terms of deciles. Points will be awarded within each decile (see table below). Clinicians who receive a score in the first or second decile will receive 3 points. Clinicians who are in the 3rd decile will receive somewhere between 3 and 3.9 points depending on their exact position in the decile, and clinicians in higher deciles will receive a corresponding number of points. For example, if a clinician submits performance data of 83% on a non-inverse measure, and the 5th decile begins at 72% and the 6th decile begins at 85%, then the clinician will receive between 5 and 5.9 points because 83% is in the 5th decile. For inverse measures where a higher performance is seen by a lower number on the performance score, the scores are reversed in the benchmark deciles (example: Measure 1). An Excel version of the 2021 MIPS Quality Historical Benchmarks can be found here

*Measures marked in blue (example: Measure 130) can only earn a maximum score of 7 points.  There are 72 Measures that meet this description.  Topped-out means that the national median performance rate is so high that there is no meaningful difference in performance between clinicians.

 

Measure NameMeasure IDCollection TypeDecile 3Decile 4Decile 5Decile 6Decile 7Decile 8Decile 9Decile 10
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)1MIPS CQM72.51 - 55.1655.17 - 41.9755.17 - 41.9741.98 - 32.5532.56 - 25.4725.48 - 19.1419.15 - 12.86<=12.87
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)1eCQM69.42 - 53.5953.6 - 42.153.6 - 42.142.11 - 34.0534.06 - 28.3128.32 - 23.5523.56 - 19.09<=19.1
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)1Medicare Part B Claims79.99 - 70.0170 - 60.0160 - 50.0150 - 40.0140 - 30.0130 - 20.0120 - 10.01<= 10
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)5eCQM1.09 - 65.5165.52 - 71.9471.95 - 75.2775.28 - 78.0878.09 - 80.4680.47 - 82.9782.98 - 86.35>= 86.36
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)5MIPS CQM6.39 - 89.9990.0 - 95.795.71 - 98.0198.02 - 99.2699.27 - 99.99----100
Coronary Artery Disease (CAD): Antiplatelet Therapy6MIPS CQM11.82 - 74.7574.76 - 86.3786.38 - 93.7493.75 - 98.6298.63 - 99.99----100
Coronary Artery Disease (CAD): Beta-Blocker Therapy - Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)7eCQM37.83 - 70.7770.78 - 80.4580.46 - 86.7286.73 - 91.6591.66 - 95.3795.38 - 97.1297.13 - 99.99100
Coronary Artery Disease (CAD): Beta-Blocker Therapy - Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)7MIPS CQM60.6 - 82.7482.75 - 89.3489.35 - 94.1894.19 - 97.797.71 - 99.99----100
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)8eCQM22.99 - 86.6886.69 - 90.1390.14 - 92.392.31 - 94.0494.05 - 100   
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)8MIPS CQM28.3 - 94.9995.0 - 97.4997.5 - 99.1399.14 - 99.99100   
Anti-Depressant Medication Management9eCQM2.38 - 65.3765.38 - 70.6870.69 - 74.3374.34 - 78.0378.04 - 80.9480.95 - 83.7683.77 - 86.66>= 86.67
Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation12eCQM0.38 - 83.6183.62 - 88.7188.72 - 92.392.31 - 95.0595.06 - 96.9696.97 - 98.3298.33 - 99.28>= 99.29
Age-Related Macular Degeneration (AMD): Dilated Macular Examination14Medicare Part B Claims2.22 - 99.99------100   
Age-Related Macular Degeneration (AMD): Dilated Macular Examination14MIPS CQM0.07 - 86.1786.18 - 91.7491.75 - 95.0195.02 - 96.9296.93 - 100   
Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care19eCQM0.04 - 54.3254.33 - 66.6666.67 - 75.3375.34 - 81.5981.6 - 87.1787.18 - 91.3691.37 - 95.07>= 95.08
Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care19MIPS CQM0.13 - 83.6183.62 - 93.5293.53 - 97.8297.83 - 99.9299.93 - 100   
Perioperative Care: Selection of Prophylactic Antibiotic - First OR Second-Generation Cephalosporin21Medicare Part B Claims0.96 - 99.99------100   
Perioperative Care: Selection of Prophylactic Antibiotic - First OR Second-Generation Cephalosporin21MIPS CQM0.16 - 78.7878.79 - 97.597.51 - 99.99--100   
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)23Medicare Part B Claims0.06 - 99.99------100   
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)23MIPS CQM0.23 - 95.4495.45 - 99.999.91 - 99.99--100   
Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older24Medicare Part B Claims33.33 - 79.379.31 - 94.2394.24 - 96.0796.08 - 99.99------100
Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older24MIPS CQM0.19 - 14.1214.13 - 36.3536.36 - 78.0678.07 - 82.8782.88 - 87.8787.88 - 93.7493.75 - 99.79>= 99.8
Screening for Osteoporosis for Women Aged 65-85 Years of Age39Medicare Part B Claims0.51 - 37.1237.13 - 49.5649.57 - 59.359.31 - 66.3766.38 - 76.0276.03 - 87.287.21 - 96.33>= 96.34
Screening for Osteoporosis for Women Aged 65-85 Years of Age39MIPS CQM0.04 - 13.413.41 - 28.5828.59 - 39.7939.8 - 51.4851.49 - 61.4661.47 - 70.3470.35 - 79.67>= 79.68
Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surgery44MIPS CQM24.04 - 94.2894.29 - 96.596.51 - 98.5698.57 - 99.99100   
Advance Care Plan47Medicare Part B Claims0.12 - 84.3884.39 - 97.4597.46 - 99.6999.7 - 99.99------100
Advance Care Plan47MIPS CQM0.01 - 20.3220.33 - 43.8343.84 - 64.4364.44 - 79.0179.02 - 89.2389.24 - 95.5995.6 - 98.94>= 98.95
Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older48MIPS CQM0.2 - 23.5523.56 - 40.0640.07 - 57.3757.38 - 73.7473.75 - 82.3882.39 - 93.0493.05 - 98.53>= 98.54
Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older50Medicare Part B Claims2.9 - 97.5597.56 - 99.99----------100
Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older50MIPS CQM0.18 - 57.6157.62 - 74.6574.66 - 84.4584.46 - 90.2790.28 - 95.8595.86 - 99.8499.85 - 99.99100
Chronic Obstructive Pulmonary Disease (COPD): Long-Acting Inhaled Bronchodilator Therapy52MIPS CQM0.16 - 84.6184.62 - 94.9995.0 - 98.2898.29 - 99.6699.67 - 100   
Appropriate Treatment for Children with Upper Respiratory Infection (URI)65eCQM14.94 - 76.1476.15 - 80.7880.79 - 84.3884.39 - 87.0987.1 - 90.190.11 - 92.8592.86 - 95.57>= 95.58
Appropriate Treatment for Children with Upper Respiratory Infection (URI)65MIPS CQM36.03 - 93.3293.33 - 95.4495.45 - 97.1397.14 - 98.4398.44 - 100   
Appropriate Testing for Children with Pharyngitis66eCQM0.28 - 52.3352.34 - 67.1567.16 - 76.0776.08 - 81.7481.75 - 85.5285.53 - 87.8387.84 - 90.68>= 90.69
Appropriate Testing for Children with Pharyngitis66MIPS CQM4.02 - 80.8480.85 - 88.0888.09 - 93.0993.1 - 97.197.11 - 99.99----100
Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow67MIPS CQM9.68 - 96.496.41 - 99.99----------100
Hematology: Chronic Lymphocytic Leukemia (CLL): Baseline Flow Cytometry70MIPS CQM5.0 - 64.4364.44 - 98.4598.46 - 99.99--------100
Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections76Medicare Part B Claims0.79 - 99.6999.7 - 99.99----100   
Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections76MIPS CQM7.5 - 97.1997.2 - 99.4299.43 - 99.99--100   
Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy - Avoidance of Inappropriate Use93Medicare Part B Claims12.86 - 93.5493.55 - 96.2996.3 - 98.198.11 - 99.99100   
Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy - Avoidance of Inappropriate Use93MIPS CQM4.0 - 83.8883.89 - 89.4589.46 - 92.8592.86 - 95.5195.52 - 100   
Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients102eCQM----------------
Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients102MIPS CQM71.43 - 90.690.61 - 97.1197.12 - 99.99--100   
Prostate Cancer: Combination Androgen Deprivation Therapy for High Risk or Very High Risk Prostate Cancer104MIPS CQM29.41 - 95.8495.85 - 99.699.61 - 99.99--100   
Adult Major Depressive Disorder (MDD): Suicide Risk Assessment107eCQM0.01 - 2.032.04 - 4.754.76 - 10.4710.48 - 22.1222.13 - 37.637.61 - 57.2257.23 - 72.48>= 72.49
Preventive Care and Screening: Influenza Immunization110Medicare Part B Claims0.08 - 63.5563.56 - 75.9775.98 - 85.2385.24 - 92.9892.99 - 98.2298.23 - 99.99--100
Preventive Care and Screening: Influenza Immunization110eCQM0.0 - 20.8520.86 - 29.8329.84 - 37.4837.49 - 44.5844.59 - 51.5451.55 - 58.6758.68 - 68.42>= 68.43
Preventive Care and Screening: Influenza Immunization110MIPS CQM0.02 - 26.9927.0 - 41.3841.39 - 54.1654.17 - 65.9665.97 - 77.777.71 - 87.9887.99 - 96.58>= 96.59
Pneumococcal Vaccination Status for Older Adults111Medicare Part B Claims0.21 - 68.6768.68 - 76.3176.32 - 82.4682.47 - 87.5687.57 - 93.0893.09 - 97.8997.9 - 99.99100
Pneumococcal Vaccination Status for Older Adults111eCQM0.01 - 20.4320.44 - 33.7133.72 - 44.6944.7 - 54.8554.86 - 63.2163.22 - 71.0971.1 - 78.79>= 78.8
Pneumococcal Vaccination Status for Older Adults111MIPS CQM0.03 - 35.135.11 - 51.2851.29 - 61.8961.9 - 69.1569.16 - 74.9975.0 - 79.8979.9 - 85.82>= 85.83
Breast Cancer Screening112Medicare Part B Claims0.75 - 66.6666.67 - 77.0777.08 - 84.8784.88 - 89.6289.63 - 93.4793.48 - 97.3597.36 - 99.02>= 99.03
Breast Cancer Screening112eCQM0.01 - 24.4324.44 - 37.1337.14 - 46.3146.32 - 54.454.41 - 61.161.11 - 67.2267.23 - 73.94>= 73.95
Breast Cancer Screening112MIPS CQM0.05 - 22.3622.37 - 39.9940.0 - 50.9750.98 - 60.2660.27 - 70.270.21 - 78.178.11 - 85.84>= 85.85
Colorectal Cancer Screening113MIPS CQM0.02 - 22.6122.62 - 41.8341.84 - 55.4355.44 - 65.1365.14 - 73.8973.9 - 81.781.71 - 90.41>= 90.42
Colorectal Cancer Screening113Medicare Part B Claims0.35 - 64.7464.75 - 76.6476.65 - 84.9684.97 - 92.0292.03 - 97.097.01 - 99.4599.46 - 99.99100
Colorectal Cancer Screening113eCQM0.0 - 15.1415.15 - 27.5127.52 - 38.7338.74 - 49.0449.05 - 58.358.31 - 67.5467.55 - 76.05>= 76.06
Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis116MIPS CQM2.78 - 62.3262.33 - 75.9976.0 - 86.3586.36 - 93.3293.33 - 96.9196.92 - 98.4298.43 - 99.99100
Diabetes: Eye Exam117Medicare Part B Claims0.75 - 97.8297.83 - 99.99----100   
Diabetes: Eye Exam117eCQM0.06 - 11.9912.0 - 20.5420.55 - 30.6830.69 - 44.8144.82 - 69.3969.4 - 94.1694.17 - 98.42>= 98.43
Diabetes: Eye Exam117MIPS CQM0.12 - 89.9289.93 - 96.6796.68 - 98.8598.86 - 99.6999.7 - 100   
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)118MIPS CQM6.67 - 72.7272.73 - 76.3176.32 - 79.679.61 - 81.8481.85 - 84.9985.0 - 86.8286.83 - 90.47>= 90.48
Diabetes: Medical Attention for Nephropathy119eCQM0.02 - 70.370.31 - 76.9176.92 - 81.5481.55 - 85.2285.23 - 88.2388.24 - 91.491.41 - 94.77>= 94.78
Diabetes: Medical Attention for Nephropathy119MIPS CQM0.53 - 71.1671.17 - 79.4779.48 - 86.6686.67 - 91.891.81 - 96.2296.23 - 98.6798.68 - 99.99100
Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy - Neurological Evaluation126MIPS CQM0.07 - 59.5459.55 - 74.7574.76 - 86.4886.49 - 94.8694.87 - 99.3199.32 - 99.99--100
Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention - Evaluation of Footwear127MIPS CQM0.06 - 58.7558.76 - 74.0274.03 - 85.0585.07 - 94.6494.65 - 99.1799.18 - 99.99--100
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan128Medicare Part B Claims0.07 - 91.4691.47 - 98.5798.58 - 99.7299.73 - 99.99------100
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan128eCQM0.01 - 23.2523.26 - 27.4127.42 - 32.6432.65 - 40.940.91 - 53.4253.43 - 69.2669.27 - 83.79>= 83.8
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan128MIPS CQM0.01 - 32.7232.73 - 51.0551.06 - 70.1670.17 - 84.6884.69 - 93.2793.28 - 98.0598.06 - 99.75>= 99.76
Documentation of Current Medications in the Medical Record130Medicare Part B Claims0.07 - 99.6699.67 - 99.9399.94 - 99.99--100   
Documentation of Current Medications in the Medical Record130eCQM0.02 - 83.7283.73 - 91.2791.28 - 94.994.91 - 96.9997.0 - 100   
Documentation of Current Medications in the Medical Record130MIPS CQM0.01 - 86.786.71 - 96.3196.32 - 98.9498.95 - 99.6799.68 - 100   
Preventive Care and Screening: Screening for Depression and Follow-Up Plan134Medicare Part B Claims0.06 - 95.9395.94 - 99.599.51 - 99.99--------100
Preventive Care and Screening: Screening for Depression and Follow-Up Plan134eCQM0.01 - 7.677.68 - 14.6214.63 - 23.4823.49 - 33.9733.98 - 45.6345.64 - 59.8359.84 - 73.85>= 73.86
Preventive Care and Screening: Screening for Depression and Follow-Up Plan134MIPS CQM0.01 - 14.7514.76 - 37.4337.44 - 55.9255.93 - 71.7371.74 - 84.6884.69 - 95.5595.56 - 99.21>= 99.22
Melanoma: Continuity of Care - Recall System137MIPS CQM0.14 - 94.9995.0 - 98.8398.84 - 99.99--------100
Melanoma: Coordination of Care138MIPS CQM0.2 - 75.575.51 - 92.5892.59 - 98.898.81 - 99.99100   
Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of Care141Medicare Part B Claims1.64 - 99.99------------100
Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of Care141MIPS CQM0.04 - 32.6132.62 - 60.3160.32 - 82.1382.14 - 93.4793.48 - 98.5498.55 - 99.99--100
Oncology: Medical and Radiation - Pain Intensity Quantified143eCQM0.44 - 67.5567.56 - 85.3185.32 - 91.8891.89 - 95.3395.34 - 97.0697.07 - 97.9597.96 - 98.79>= 98.8
Oncology: Medical and Radiation - Pain Intensity Quantified143MIPS CQM1.6 - 93.6493.65 - 97.6597.66 - 99.299.21 - 99.8399.84 - 100   
Oncology: Medical and Radiation - Plan of Care for Moderate to Severe Pain144MIPS CQM2.38 - 70.2970.3 - 86.2686.27 - 92.392.31 - 97.0597.06 - 99.1399.14 - 99.99--100
Radiology: Exposure Dose Indices or Exposure Time and Number of Images Reported for Procedures Using Fluoroscopy145Medicare Part B Claims0.38 - 85.785.71 - 94.4394.44 - 97.6197.62 - 99.1899.19 - 100   
Radiology: Exposure Dose Indices or Exposure Time and Number of Images Reported for Procedures Using Fluoroscopy145MIPS CQM0.11 - 86.686.61 - 95.4795.48 - 98.498.41 - 99.7299.73 - 100   
Radiology: Inappropriate Use of "Probably Benign" Assessment Category in Screening Mammograms146MIPS CQM0.54 - 0.20.19 - 0.10.09 - 0.040.03 - 0.010   
Radiology: Inappropriate Use of "Probably Benign" Assessment Category in Screening Mammograms146Medicare Part B Claims0.75 - 0.30.29 - 0.140.13 - 0.01--0   
Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy147Medicare Part B Claims3.57 - 71.4271.43 - 85.785.71 - 95.4495.45 - 98.4598.46 - 100   
Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy147MIPS CQM4.12 - 93.6593.66 - 98.9198.92 - 99.99--100   
Falls: Risk Assessment154Medicare Part B Claims0.48 - 99.0699.07 - 99.99----100   
Falls: Risk Assessment154MIPS CQM0.14 - 87.8587.86 - 96.1296.13 - 98.8198.82 - 99.99100   
Falls: Plan of Care155Medicare Part B Claims0.79 - 87.4987.5 - 98.0798.08 - 99.99--------100
Falls: Plan of Care155MIPS CQM0.14 - 85.8785.88 - 93.8793.88 - 97.8397.84 - 99.99------100
Coronary Artery Bypass Graft (CABG): Prolonged Intubation164MIPS CQM10.87 - 8.818.8 - 7.77.69 - 5.885.87 - 5.015.0 - 3.533.52 - 2.642.63 - 1.6<= 1.59
Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure167MIPS CQM4.81 - 3.613.6 - 2.452.44 - 2.052.04 - 1.481.47 - 1.231.22 - 0.560.55 - 0.010
Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration168MIPS CQM6.12 - 3.053.04 - 2.492.48 - 2.152.14 - 1.561.55 - 1.221.21 - 0.490.48 - 0.010
Rheumatoid Arthritis (RA): Tuberculosis Screening176MIPS CQM1.2 - 51.651.61 - 77.6277.63 - 89.789.71 - 93.1993.2 - 97.3697.37 - 99.99--100
Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity177MIPS CQM0.13 - 65.4865.49 - 75.1975.2 - 85.3785.38 - 91.0391.04 - 95.2195.22 - 98.2298.23 - 99.66>= 99.67
Rheumatoid Arthritis (RA): Functional Status Assessment178MIPS CQM0.23 - 76.2776.28 - 89.3989.4 - 94.2594.26 - 97.7197.72 - 100   
Rheumatoid Arthritis (RA): Glucocorticoid Management180MIPS CQM0.26 - 98.2598.26 - 99.6899.69 - 99.99--------100
Elder Maltreatment Screen and Follow-Up Plan181Medicare Part B Claims0.08 - 98.8798.88 - 99.99----------100
Elder Maltreatment Screen and Follow-Up Plan181MIPS CQM0.74 - 58.5158.52 - 78.6578.66 - 89.1289.13 - 95.6595.66 - 98.9198.92 - 99.99--100
Functional Outcome Assessment182Medicare Part B Claims0.04 - 99.5599.56 - 99.99----------100
Functional Outcome Assessment182MIPS CQM0.01 - 98.5698.57 - 99.5899.59 - 99.8399.84 - 99.99------100
Colonoscopy Interval for Patients with a History of Adenomatous Polyps - Avoidance of Inappropriate Use185MIPS CQM0.17 - 44.6144.62 - 81.2481.25 - 90.5890.59 - 95.7395.74 - 98.0498.05 - 99.5499.55 - 99.99100
Stroke and Stroke Rehabilitation: Thrombolytic Therapy187MIPS CQM8.74 - 82.7382.74 - 88.3188.32 - 91.6691.67 - 93.5493.55 - 100   
Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery191eCQM0.31 - 88.0388.04 - 93.4593.46 - 95.795.71 - 97.1297.13 - 98.2298.23 - 98.8598.86 - 99.49>= 99.5
Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery191MIPS CQM16.82 - 94.1694.17 - 96.2996.3 - 97.4397.44 - 98.4498.45 - 99.4499.45 - 99.99--100
Radiology: Stenosis Measurement in Carotid Imaging Reports195Medicare Part B Claims1.05 - 97.7697.77 - 99.3999.4 - 99.99--100   
Radiology: Stenosis Measurement in Carotid Imaging Reports195MIPS CQM0.38 - 99.2799.28 - 99.8399.84 - 99.99--100   
HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis205MIPS CQM----------------
Functional Status Change for Patients with Knee Impairments217MIPS CQM16.74 - 95.2295.23 - 96.5896.59 - 98.498.41 - 99.99------100
Functional Status Change for Patients with Hip Impairments218MIPS CQM13.44 - 94.5494.55 - 95.5595.56 - 98.8398.84 - 99.99------100
Functional Status Change for Patients with Lower Leg, Foot or Ankle Impairments219MIPS CQM67.86 - 94.0794.08 - 95.3795.38 - 97.4997.5 - 98.9798.98 - 99.99----100
Functional Status Change for Patients with Low Back Impairments220MIPS CQM12.68 - 91.3291.33 - 95.1395.14 - 96.6696.67 - 98.5598.56 - 99.99----100
Functional Status Change for Patients with Shoulder Impairments221MIPS CQM59.21 - 95.3195.32 - 97.1597.16 - 98.3898.39 - 99.1299.13 - 99.99----100
Functional Status Change for Patients with Elbow, Wrist or Hand Impairments222MIPS CQM35.16 - 94.4394.44 - 96.6696.67 - 97.797.71 - 99.99------100
Radiology: Reminder System for Screening Mammograms225Medicare Part B Claims0.1 - 99.99------------100
Radiology: Reminder System for Screening Mammograms225MIPS CQM0.01 - 99.99------------100
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention226Medicare Part B Claims----------------
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention226eCQM----------------
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention226MIPS CQM----------------
Controlling High Blood Pressure236Medicare Part B Claims20 - 29.9930 - 39.9940 - 49.9950 - 59.9960 - 69.9970 - 79.9980 - 89.99>= 90
Controlling High Blood Pressure236MIPS CQM20 - 29.9930 - 39.9940 - 49.9950 - 59.9960 - 69.9970 - 79.9980 - 89.99>= 90
Controlling High Blood Pressure236eCQM0.07 - 51.6851.69 - 57.0757.08 - 61.3261.33 - 64.7964.8 - 68.4468.45 - 72.0372.04 - 76.35>= 76.36
Use of High-Risk Medications in the Elderly238MIPS CQM----------------
Use of High-Risk Medications in the Elderly238eCQM----------------
Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents239eCQM0.02 - 27.4627.47 - 30.4830.49 - 32.1232.13 - 33.3233.33 - 34.4734.48 - 38.5338.54 - 47.92>= 47.93
Childhood Immunization Status240eCQM0.52 - 17.9217.93 - 25.5325.54 - 32.3932.4 - 36.7436.75 - 40.1840.19 - 44.7344.74 - 49.56>= 49.57
Cardiac Rehabilitation Patient Referral from an Outpatient Setting243MIPS CQM3.39 - 19.0119.02 - 25.6325.64 - 31.4231.43 - 37.1337.14 - 42.8542.86 - 48.9748.98 - 63.7>= 63.71
Barrett's Esophagus249Medicare Part B Claims90.48 - 99.99------100   
Barrett's Esophagus249MIPS CQM57.76 - 99.99------100   
Radical Prostatectomy Pathology Reporting250Medicare Part B Claims32.08 - 99.99------100   
Radical Prostatectomy Pathology Reporting250MIPS CQM92.21 - 99.99------100   
Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal Pain254Medicare Part B Claims----------------
Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal Pain254MIPS CQM6.9 - 88.6388.64 - 92.2492.25 - 95.2595.26 - 96.7696.77 - 100   
Rate of Open Repair of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #7)258MIPS CQM----------------
Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post Operative Day #2)259MIPS CQM----------------
Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2)260MIPS CQM----------------
Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness261Medicare Part B Claims----------------
Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness261MIPS CQM----------------
Sentinel Lymph Node Biopsy for Invasive Breast Cancer264MIPS CQM----------------
Biopsy Follow-Up265MIPS CQM0.06 - 78.3878.39 - 95.495.41 - 99.0799.08 - 99.99100   
Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy268MIPS CQM0.18 - 14.4814.49 - 23.9924.0 - 39.2139.22 - 49.9950.0 - 65.4765.48 - 89.4989.5 - 94.99>= 95.0
Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy275MIPS CQM----------------
Sleep Apnea: Severity Assessment at Initial Diagnosis277MIPS CQM0.23 - 23.9924.0 - 42.7942.8 - 58.2258.23 - 71.6471.65 - 93.0993.1 - 99.8699.87 - 99.99100
Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy279MIPS CQM0.23 - 88.1488.15 - 95.6495.65 - 98.6898.69 - 99.99100   
Dementia: Cognitive Assessment281eCQM0.04 - 8.328.33 - 13.6313.64 - 21.7321.74 - 31.5731.58 - 44.8244.83 - 59.7359.74 - 73.9>= 73.91
Dementia: Functional Status Assessment282MIPS CQM0.12 - 43.5343.54 - 68.1768.18 - 91.0391.04 - 98.2398.24 - 99.99----100
Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management283MIPS CQM0.12 - 74.9975.0 - 92.4492.45 - 96.3696.37 - 98.6798.68 - 100   
Dementia: Safety Concern Screening and Follow-Up for Patients with Dementia286MIPS CQM0.12 - 86.3586.36 - 93.3793.38 - 97.6697.67 - 99.99100   
Dementia: Education and Support of Caregivers for Patients with Dementia288MIPS CQM0.21 - 43.2743.28 - 66.6666.67 - 83.3283.33 - 95.3895.39 - 98.3298.33 - 99.99--100
Parkinson's Disease: Psychiatric Symptoms Assessment for Patients with Parkinson's Disease290MIPS CQM1.15 - 34.3834.39 - 57.4657.47 - 81.0781.08 - 92.0592.06 - 98.0598.06 - 99.99--100
Parkinson's Disease: Cognitive Impairment or Dysfunction Assessment for Patients with Parkinson's Disease291MIPS CQM1.79 - 25.5625.57 - 59.8859.89 - 89.2789.28 - 98.9398.94 - 100   
Parkinson's Disease: Rehabilitative Therapy Options293MIPS CQM0.4 - 48.3448.35 - 65.765.71 - 85.785.71 - 93.7293.73 - 100   
Cataracts: Improvement in Patient's Visual Function within 90 Days Following Cataract Surgery303MIPS CQM----------------
Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery304MIPS CQM----------------
Initiation and Engagement of Alcohol and Other Drug Dependence Treatment305eCQM0.02 - 0.260.27 - 0.420.43 - 0.630.64 - 0.910.92 - 1.241.25 - 1.841.85 - 2.9>= 2.91
Cervical Cancer Screening309eCQM0.01 - 11.3511.36 - 18.3618.37 - 24.9925.0 - 32.2832.29 - 39.5639.57 - 46.846.81 - 55.55>= 55.56
Chlamydia Screening for Women310eCQM0.1 - 19.8719.88 - 26.6626.67 - 32.1932.2 - 37.6537.66 - 42.4642.47 - 47.4947.5 - 56.06>= 56.07
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented317Medicare Part B Claims----------------
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented317eCQM----------------
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented317MIPS CQM----------------
Falls: Screening for Future Fall Risk318eCQM0.01 - 18.818.81 - 36.2736.28 - 52.3352.34 - 66.6466.65 - 78.7178.72 - 87.4987.5 - 94.18>= 94.19
Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients320Medicare Part B Claims5.61 - 92.6792.68 - 99.0699.07 - 99.99--100   
Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients320MIPS CQM0.23 - 81.6881.69 - 89.0189.02 - 93.2993.3 - 95.895.81 - 100   
Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low-Risk Surgery Patients322MIPS CQM3.47 - 0.340.33 - 0.01----------0
Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI)323MIPS CQM0.26 - 0.01------------0
Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk Patients324MIPS CQM9.11 - 2.522.51 - 0.720.71 - 0.01--------0
Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy326Medicare Part B Claims6.67 - 98.6298.63 - 99.99----100   
Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy326MIPS CQM0.95 - 79.0979.1 - 83.6783.68 - 88.4588.46 - 94.594.51 - 100   
Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse)331MIPS CQM87.84 - 75.9675.95 - 62.5162.5 - 50.1350.12 - 37.5837.57 - 25.1325.12 - 14.8214.81 - 5.29<= 5.28
Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use)332MIPS CQM18.88 - 52.4352.44 - 61.3661.37 - 72.6372.64 - 85.7585.76 - 89.9389.94 - 96.1296.13 - 99.99100
Maternity Care: Elective Delivery or Early Induction Without Medical Indication at < 39 Weeks (Overuse)335MIPS CQM----------------
Maternity Care: Postpartum Follow-up and Care Coordination336MIPS CQM----------------
Psoriasis: Tuberculosis (TB) Prevention for Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis on a Biological Immune Response Modifier337MIPS CQM0.57 - 67.9968.0 - 80.7680.77 - 88.8888.89 - 94.4194.42 - 97.5397.54 - 99.99--100
HIV Viral Load Suppression338MIPS CQM2.86 - 76.8876.89 - 84.284.21 - 87.3287.33 - 91.5491.55 - 95.3695.37 - 96.9696.97 - 99.99100
HIV Medical Visit Frequency340MIPS CQM37.42 - 54.7954.8 - 60.0860.09 - 69.9970.0 - 74.9975.0 - 84.584.51 - 98.4798.48 - 99.99100
Pain Brought Under Control Within 48 Hours342MIPS CQM32.56 - 99.99------------100
Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2)344MIPS CQM----------------
Total Knee Replacement: Shared Decision-Making: Trial of Conservative (Non-surgical) Therapy350MIPS CQM2.22 - 99.5999.6 - 99.99----100   
Total Knee Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation351MIPS CQM1.75 - 99.3599.36 - 99.99----100   
Anastomotic Leak Intervention354MIPS CQM6.52 - 3.243.23 - 1.81.79 - 0.01--------0
Unplanned Reoperation within the 30 Day Postoperative Period355MIPS CQM5.08 - 2.462.45 - 1.341.33 - 0.80.79 - 0.190.18 - 0.01----0
Unplanned Hospital Readmission within 30 Days of Principal Procedure356MIPS CQM8.33 - 5.775.76 - 3.963.95 - 2.792.78 - 1.11.09 - 0.01----0
Surgical Site Infection (SSI)357MIPS CQM7.5 - 3.343.33 - 1.831.82 - 0.780.77 - 0.01------0
Patient-Centered Surgical Risk Assessment and Communication358MIPS CQM0.34 - 34.6134.62 - 72.4272.43 - 91.2291.23 - 98.598.51 - 99.99----100
Optimizing Patient Exposure to Ionizing Radiation: Count of Potential High Dose Radiation Imaging Studies: Computed Tomography (CT) and Cardiac Nuclear Medicine Studies360MIPS CQM0.01 - 85.585.51 - 98.7698.77 - 99.9399.94 - 99.99100   
Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended Guidelines364MIPS CQM21.4 - 95.8295.83 - 98.198.11 - 99.99--------100
Follow-Up Care for Children Prescribed ADHD Medication (ADD)366eCQM1.19 - 20.320.31 - 24.1324.14 - 29.5429.55 - 35.9435.95 - 39.5239.53 - 45.4845.49 - 50.58>= 50.59
Depression Remission at Twelve Months370MIPS CQM----------------
Depression Remission at Twelve Months370eCQM0.34 - 3.643.65 - 4.914.92 - 6.336.34 - 7.67.61 - 9.629.63 - 11.9912.0 - 14.99>= 15.0
Closing the Referral Loop: Receipt of Specialist Report374eCQM0.02 - 9.719.72 - 16.9716.98 - 25.525.51 - 34.9234.93 - 46.4246.43 - 59.9960.0 - 74.59>= 74.6
Closing the Referral Loop: Receipt of Specialist Report374MIPS CQM0.03 - 59.9960.0 - 77.5477.55 - 92.392.31 - 97.5497.55 - 99.99----100
Functional Status Assessment for Total Knee Replacement375eCQM0.12 - 8.188.19 - 10.3110.32 - 14.8314.84 - 21.0921.1 - 29.0829.09 - 37.4937.5 - 51.34>= 51.35
Functional Status Assessment for Total Hip Replacement376eCQM0.23 - 4.724.73 - 8.328.33 - 11.5311.54 - 15.8215.83 - 19.7419.75 - 33.3233.33 - 53.56>= 53.57
Functional Status Assessments for Congestive Heart Failure377eCQM----------------
Children Who Have Dental Decay or Cavities378eCQM1.67 - 0.880.87 - 0.390.38 - 0.01--------0
Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists379eCQM0.0 - 0.250.26 - 0.530.54 - 1.091.1 - 2.182.19 - 3.843.85 - 5.225.23 - 7.3>= 7.31
Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment382eCQM0.04 - 7.447.45 - 12.4912.5 - 19.1119.12 - 29.7929.8 - 39.0839.09 - 47.147.11 - 58.7>= 58.71
Adherence to Antipsychotic Medications For Individuals with Schizophrenia383MIPS CQM0.75 - 51.5151.52 - 80.8480.85 - 96.5196.52 - 99.99------100
Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room Within 90 Days of Surgery384MIPS CQM60.0 - 95.9996.0 - 99.99----------100
Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement Within 90 Days of Surgery385MIPS CQM10.11 - 42.8542.86 - 47.9948.0 - 51.0551.06 - 58.2758.28 - 66.6666.67 - 71.4271.43 - 75.7>= 75.71
Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences386MIPS CQM----------------
Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users387MIPS CQM----------------
Cataract Surgery: Difference Between Planned and Final Refraction389MIPS CQM0.93 - 30.4730.48 - 38.5338.54 - 51.9451.95 - 71.0771.08 - 94.4594.46 - 98.1898.19 - 99.99100
Follow-Up After Hospitalization for Mental Illness (FUH)391MIPS CQM----------------
Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation Ablation392MIPS CQM----------------
Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision393MIPS CQM----------------
Immunizations for Adolescents394MIPS CQM1.04 - 3.273.28 - 7.687.69 - 18.5818.59 - 22.7222.73 - 23.9623.97 - 30.4230.43 - 38.72>= 38.73
Lung Cancer Reporting (Biopsy/Cytology Specimens)395Medicare Part B Claims75.0 - 99.99------100   
Lung Cancer Reporting (Biopsy/Cytology Specimens)395MIPS CQM2.01 - 99.99------100   
Lung Cancer Reporting (Resection Specimens)396Medicare Part B Claims95.24 - 99.99------100   
Lung Cancer Reporting (Resection Specimens)396MIPS CQM84.62 - 99.99------100   
Melanoma Reporting397Medicare Part B Claims81.82 - 99.99------100   
Melanoma Reporting397MIPS CQM3.03 - 99.99------100   
Optimal Asthma Control398MIPS CQM0.44 - 33.3233.33 - 49.2849.29 - 58.0458.05 - 80.1380.14 - 99.99----100
One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk400MIPS CQM0.08 - 1.381.39 - 2.022.03 - 3.933.94 - 9.289.29 - 18.0218.03 - 28.7728.78 - 43.81>= 43.82
Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis401MIPS CQM----------------
Tobacco Use and Help with Quitting Among Adolescents402MIPS CQM0.18 - 88.1388.14 - 93.5493.55 - 96.5496.55 - 98.4598.46 - 100   
Anesthesiology Smoking Abstinence404MIPS CQM1.1 - 53.2653.27 - 62.1962.2 - 68.1768.18 - 73.1773.18 - 79.1879.19 - 84.4284.43 - 91.75>= 91.76
Appropriate Follow-up Imaging for Incidental Abdominal Lesions405MIPS CQM0.03 - 1.091.1 - 1.521.53 - 2.462.47 - 3.563.57 - 4.754.76 - 9.589.59 - 14.99>= 15.0
Appropriate Follow-up Imaging for Incidental Abdominal Lesions405Medicare Part B Claims0.05 - 3.323.33 - 4.544.55 - 6.736.74 - 9.519.52 - 11.9912.0 - 13.7813.79 - 21.73>= 21.74
Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients406Medicare Part B Claims5.0 - 0.410.4 - 0.01----0   
Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients406MIPS CQM10.81 - 2.282.27 - 0.01----0   
Opioid Therapy Follow-up Evaluation408MIPS CQM0.21 - 78.978.91 - 93.3193.32 - 98.7798.78 - 99.8899.89 - 100   
Clinical Outcome Post Endovascular Stroke Treatment409MIPS CQM----------------
Psoriasis: Clinical Response to Systemic Medications410MIPS CQM1.54 - 56.1156.12 - 70.5870.59 - 79.9980.0 - 87.8787.88 - 93.3293.33 - 97.4397.44 - 99.99100
Documentation of Signed Opioid Treatment Agreement412MIPS CQM0.09 - 34.6734.68 - 75.4975.5 - 96.3396.34 - 99.8499.85 - 100   
Door to Puncture Time for Endovascular Stroke Treatment413MIPS CQM----------------
Evaluation or Interview for Risk of Opioid Misuse414MIPS CQM0.12 - 93.3593.36 - 99.3999.4 - 99.99--100   
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older415MIPS CQM17.39 - 83.7283.73 - 90.990.91 - 94.4394.44 - 96.3996.4 - 97.5597.56 - 98.5498.55 - 99.41>= 99.42
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years416MIPS CQM45.24 - 27.2227.21 - 20.0120.0 - 12.1312.12 - 5.895.88 - 3.463.45 - 2.052.04 - 0.010
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years416Medicare Part B Claims----------------
Osteoporosis Management in Women Who Had a Fracture418Medicare Part B Claims----------------
Osteoporosis Management in Women Who Had a Fracture418MIPS CQM----------------
Overuse of Imaging for the Evaluation of Primary Headache419MIPS CQM50.12 - 28.5328.52 - 16.3616.35 - 10.4410.43 - 5.365.35 - 3.243.23 - 1.631.62 - 0.21<= 0.2
Varicose Vein Treatment with Saphenous Ablation: Outcome Survey420MIPS CQM----------------
Appropriate Assessment of Retrievable Inferior Vena Cava (IVC) Filters for Removal421MIPS CQM----------------
Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury422MIPS CQM----------------
Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury422Medicare Part B Claims----------------
Perioperative Temperature Management424MIPS CQM5.0 - 98.2198.22 - 99.2699.27 - 99.6899.69 - 99.8599.86 - 99.9699.97 - 99.99--100
Photodocumentation of Cecal Intubation425Medicare Part B Claims87.8 - 98.7998.8 - 99.4399.44 - 99.99--------100
Photodocumentation of Cecal Intubation425MIPS CQM3.17 - 89.0989.1 - 94.7794.78 - 96.7296.73 - 97.9597.96 - 98.5598.56 - 99.1299.13 - 99.47>= 99.48
Pelvic Organ Prolapse: Preoperative Screening for Uterine Malignancy429Medicare Part B Claims----------------
Pelvic Organ Prolapse: Preoperative Screening for Uterine Malignancy429MIPS CQM----------------
Prevention of Post-Operative Nausea and Vomiting (PONV) - Combination Therapy430MIPS CQM1.36 - 96.6796.68 - 98.1798.18 - 98.9398.94 - 99.4999.5 - 100   
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling431MIPS CQM----------------
Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair432MIPS CQM----------------
Proportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse Repair433MIPS CQM----------------
Proportion of Patients Sustaining a Ureter Injury at the Time of Pelvic Organ Prolapse Repair434MIPS CQM----------------
Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques436Medicare Part B Claims0.09 - 96.4996.5 - 98.6798.68 - 99.5699.57 - 99.8799.88 - 100   
Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques436MIPS CQM0.02 - 98.9598.96 - 99.7699.77 - 99.9699.97 - 99.99100   
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease438eCQM0.42 - 62.4662.47 - 66.2166.22 - 68.9668.97 - 71.3671.37 - 73.7473.75 - 76.0776.08 - 79.56>= 79.57
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease438MIPS CQM15.16 - 67.367.31 - 73.0273.03 - 76.4976.5 - 82.3982.4 - 87.4387.44 - 93.0993.1 - 99.99100
Age Appropriate Screening Colonoscopy439MIPS CQM----------------
Skin Cancer: Biopsy Reporting Time - Pathologist to Clinician440MIPS CQM2.54 - 98.3598.36 - 99.7199.72 - 99.99--100   
Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)441MIPS CQM0.01 - 12.7512.76 - 22.3222.33 - 27.5527.56 - 36.4436.45 - 42.5442.55 - 48.4748.48 - 55.55>= 55.56
Non-Recommended Cervical Cancer Screening in Adolescent Females443MIPS CQM----------------
Medication Management for People with Asthma444MIPS CQM----------------
Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)445MIPS CQM5.19 - 4.014.0 - 2.982.97 - 2.412.4 - 1.951.94 - 1.051.04 - 0.680.67 - 0.010
Appropriate Workup Prior to Endometrial Ablation448MIPS CQM----------------
Trastuzumab Received By Patients With AJCC Stage I (T1c) - III And HER2 Positive Breast Cancer Receiving Adjuvant Chemotherapy450MIPS CQM----------------
RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy451MIPS CQM----------------
Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies452MIPS CQM----------------
Percentage of Patients Who Died from Cancer Receiving Chemotherapy in the Last 14 Days of Life (lower score - better)453MIPS CQM22.73 - 18.1918.18 - 15.5715.56 - 13.9613.95 - 11.2811.27 - 10.0110.0 - 8.588.57 - 6.07<= 6.06
Percentage of Patients Who Died from Cancer Admitted to the Intensive Care Unit (ICU) in the Last 30 Days of Life (lower score - better)455MIPS CQM----------------
Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score - better)457MIPS CQM16.0 - 11.3311.32 - 10.0110.0 - 8.178.16 - 6.996.98 - 4.274.26 - 3.043.03 - 2.23<= 2.22
Back Pain After Lumbar Discectomy/Laminectomy459MIPS CQM----------------
Back Pain After Lumbar Fusion460MIPS CQM----------------
Leg Pain After Lumbar Discectomy/Laminectomy461MIPS CQM----------------
Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy462eCQM----------------
Prevention of Post-Operative Vomiting (POV) - Combination Therapy (Pediatrics)463MIPS CQM24.19 - 94.5894.59 - 97.2997.3 - 98.2498.25 - 99.0799.08 - 100   
Otitis Media with Effusion: Systemic Antimicrobials - Avoidance of Inappropriate Use464MIPS CQM24.0 - 84.4684.47 - 87.5287.53 - 89.9990.0 - 92.7492.75 - 94.5394.54 - 96.1496.15 - 97.59>= 97.6
Uterine Artery Embolization Technique: Documentation of Angiographic Endpoints and Interrogation of Ovarian Arteries465MIPS CQM----------------
Continuity of Pharmacotherapy for Opioid Use Disorder (OUD)468MIPS CQM----------------
Functional Status After Lumbar Fusion469MIPS CQM----------------
Functional Status After Primary Total Knee Replacement470MIPS CQM----------------
Functional Status After Lumbar Discectomy/Laminectomy471MIPS CQM----------------
Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture472eCQM----------------
Leg Pain After Lumbar Fusion473MIPS CQM----------------
HIV Screening475eCQM0.12 - 1.451.46 - 2.442.45 - 5.315.32 - 9.489.49 - 25.525.51 - 99.99--100
International Prostate Symptom Score (IPSS) or American Urological Association-Symptom Index (AUA-SI) Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia476eCQM----------------
Multimodal Pain Management477MIPS CQM----------------
Functional Status Change for Patients with Neck Impairments478MIPS CQM----------------

Register with MDinteractive